Dreyer Scott's Form 4/A amendment
AmendedCollegium Pharmaceutical, Inc (COLL) · filed Mar 18, 2025
- Accession no.
- 0001062993-25-005834
- Filed
- Mar 18, 2025
- Trade date
- Mar 11, 2025
- Filing delay
- 7 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Mar 13, 2025
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $461.6K. It was filed 7 days after the trade.
This amendment replaces 0001062993-25-005396 (filed Mar 13, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dreyer ScottCIK 0001746251 | Officer (EVP & Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Common Stock | SSaleDisposed | −15,387 | $30.00 | −$461,610 | 126,676 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.